Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Novonesis expects results from weight-loss drug supplement study in 2027

Summary by WTVB
By Vera Dvorakova and Jesus Calero Aug 20 (Reuters) - Danish biosolutions maker Novonesis expects results in the second half of 2027 from research with Novo Nordisk into whether ​microbiome supplements could provide additional benefits alongside GLP-1 ...

1 Articles

WTVBWTVB
Center

Novonesis expects results from weight-loss drug supplement study in 2027

By Vera Dvorakova and Jesus Calero Aug 20 (Reuters) - Danish biosolutions maker Novonesis expects results in the second half of 2027 from research with Novo Nordisk into whether ​microbiome supplements could provide additional benefits alongside GLP-1 ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WTVB broke the news on Thursday, August 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

Novo Nordisk icon

Novo Nordisk

Denmark icon

Denmark

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal